Insider trades
Christopher Mutz, Executive of Ani Pharmaceuticals ANIP, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $1.6M. The latest trade was on 03/13.
Christopher Mutz
Head of Rare Disease
- Company
- Ani Pharmaceuticals ANIP
- First filing
- 23/02/17
- Trades
- 33 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- −$1.6M
- Last trade
- 03/13
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 03/13 | 03/13 | 3,162 sh | $71.64 | $226,525.68 | −3.3% | |
ANIP | Open-market sale10b5-1 plan | 03/06–03/09 | 03/10 | 5,723 sh2 trades | $74.19avg. | $424,616.98 | −5.7% |
| Open-market sale10b5-1 plan | 03/02 | 03/04 | 417 sh | $74.00 | $30,858 | −0.4% | |
| Open-market sale10b5-1 plan | 02/20 | 02/23 | 5,323 sh | $78.02 | $415,300.46 | −5.9% | |
| Open-market sale10b5-1 plan | 02/12 | 02/17 | 7,032 sh | $76.55 | $538,299.6 | −7.1% | |
| Open-market sale | 25/05/14 | 25/05/15 | 4,000 sh | $60.45 | $241,800 | −3.6% | |
| Open-market sale | 24/11/15 | 24/11/18 | 6,500 sh | $57.70 | $375,050 | −7.8% | |
| Open-market sale | 24/05/21 | 24/05/22 | 2,000 sh | $61.61 | $123,220 | −2.3% | |
| Open-market sale | 24/03/05 | 24/03/06 | 5,000 sh | $66.00 | $330,000 | −5.4% | |
| Open-market sale | 23/11/10 | 23/11/13 | 3,000 sh | $52.47 | $157,410 | −4.5% |